Intellipharmaceutics International Inc. Quarterly Retained Earnings (Accumulated Deficit) in CAD from Q4 2015 to Q4 2018

Taxonomy & unit: us-gaap: CAD and USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: Intellipharmaceutics International Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2015 to Q4 2018.
Intellipharmaceutics International Inc. Retained Earnings (Accumulated Deficit) for the quarter ending November 30, 2018 was -CA$85.6M, a 19.1% decline year-over-year.

Retained Earnings (Accumulated Deficit), Quarterly (CAD)

Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2018	-85.6M	-13.7M	-19.1%	Nov 30, 2018	20-F/A	2019-03-04
Q4 2017	-71.9M	-8.86M	-14.1%	Nov 30, 2017	20-F/A	2019-03-04
Q2 2017	-66.8M			May 31, 2017	6-K	2017-07-11
Q1 2017	-65M			Feb 28, 2017	6-K	2017-04-12
Q4 2016	-63M	-10.1M	-19.2%	Nov 30, 2016	20-F	2018-03-01
Q4 2015	-52.9M			Nov 30, 2015	20-F	2017-02-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.